Mebaral
Patient Information
PATIENT INFORMATION
Practitioners should give the following information and instructions to patients receiving barbiturates.
- The use of barbiturates carries with it an associated risk of psychological and/or physical dependence. The patient should be warned against increasing the dose of the drug without consulting a physician.
- Barbiturates may impair mental and/or physical abilities required for the performance of potentially hazardous tasks. (e.g., driving, operating machinery, etc.)
- Alcohol should not be consumed while taking barbiturates. Concurrent use of the barbiturates with other CNS depressants (e.g., alcohol, narcotics, tranquilizers, and antihistamines) may result in additional CNS depressant effects.
Brand Name: Mebaral
Generic Name: Mephobarbital
Generic Name: Mephobarbital
« Previous: Mebaral - Clinical Pharmacology
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Epilepsy
Find tips and treatments to control seizures.
Brain Surgery in Epileptics
A new method for treating children with epilepsy involves pinpoint mapping of the brain and removing those epileptic seizure points. See more WebMD Videos »
